主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANIP
#2094
ANI Pharmaceuticals, Inc.
76.880
0
USD
+0.52%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
+0.52%
每月变动
+6.36%
6个月变化
-18.76%
年变化
-18.76%
前一天收盘价
76.480
0
开盘价
76.500
0
买价
卖价
最低价
76.500
0
High
77.255
0
交易量
12
市场
股票
医疗保健
ANIP
展开完整图表
Financials
概览
声明
统计
每季度
年度
利润表
资产负债表
现金流
值
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
经营活动产生的现金
15.86 M
34.99 M
75.81 M
44.05 M
30.37 M
185.22 M
投资活动产生的现金
-10.68 M
-19.85 M
-6.91 M
-6.16 M
-1.4 M
-34.32 M
融资活动产生的现金
-4.91 M
-9.91 M
-1.75 M
6.34 M
-4.64 M
-9.94 M
自由现金流
13.38 M
15.14 M
68.9 M
37.89 M
28.96 M
150.9 M
新闻
New Strong Buy Stocks for April 16th
CGON Stock Up 60.8% in Six Months: Here's What You Need to Know
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
ANI Pharmaceuticals Stock: Undervalued Cortrophin Drives Rare Disease Growth (NASDAQ:ANIP)
Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties
Is American Well (AMWL) Outperforming Other Medical Stocks This Year?
Insmed Ends Brinsupri Development in Skin Disease Post Study Failure
ANI Pharmaceuticals Stock: Worthy Of A Position (NASDAQ:ANIP)
Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD